BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 123 filers reported holding BIOSCRIP INC in Q4 2014. The put-call ratio across all filers is 10.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,000 | 0.0% | 1,100 | +120.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | +100.0% | 500 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 500 | +66.7% | 0.00% | – |
| Q1 2018 | $1,000 | -66.7% | 300 | -89.8% | 0.00% | – |
| Q4 2016 | $3,000 | -66.7% | 2,936 | -41.5% | 0.00% | – |
| Q4 2015 | $9,000 | -87.8% | 5,021 | -87.3% | 0.00% | -100.0% |
| Q3 2015 | $74,000 | -86.9% | 39,531 | -74.6% | 0.00% | -87.5% |
| Q2 2015 | $565,000 | +1612.1% | 155,767 | +1971.9% | 0.01% | +700.0% |
| Q1 2015 | $33,000 | +43.5% | 7,518 | +124.8% | 0.00% | – |
| Q3 2014 | $23,000 | -77.5% | 3,344 | -72.6% | 0.00% | -100.0% |
| Q2 2014 | $102,000 | -66.9% | 12,199 | -72.3% | 0.00% | -60.0% |
| Q1 2014 | $308,000 | +25.2% | 44,101 | +32.7% | 0.01% | +25.0% |
| Q4 2013 | $246,000 | +6.5% | 33,244 | +26.3% | 0.00% | 0.0% |
| Q3 2013 | $231,000 | – | 26,324 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELberon, LLC | 2,334,000 | $5,952,000 | 11.88% |
| Alta Fundamental Advisers LLC | 2,250,000 | $5,738,000 | 7.23% |
| Coliseum Capital Management, LLC | 5,622,410 | $14,337,000 | 5.98% |
| WYNNEFIELD CAPITAL INC | 3,473,500 | $8,857,000 | 3.20% |
| First Light Asset Management, LLC | 2,092,082 | $5,335,000 | 2.47% |
| NORTH TIDE CAPITAL, LLC | 8,500,000 | $21,675,000 | 2.42% |
| ARDSLEY ADVISORY PARTNERS LP | 5,417,500 | $13,815,000 | 2.40% |
| Millrace Asset Group, Inc. | 543,862 | $1,387,000 | 2.26% |
| Keane Capital Partners, LLC | 271,100 | $691,000 | 1.64% |
| Monashee Investment Management LLC | 405,000 | $1,033,000 | 1.63% |